Skip to main content
Clinical Trials/NL-OMON26359
NL-OMON26359
Not Yet Recruiting
N/A

Microvascular changes and microvascular reactivity in stable patients with Chronic Obstructive Pulmonary Disease using non-invasive retinal imaging

VITO and CIRO0 sites246 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
VITO and CIRO
Enrollment
246
Status
Not Yet Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational non invasive

Investigators

Sponsor
VITO and CIRO

Eligibility Criteria

Inclusion Criteria

  • COPD as a primary diagnosis according to the Global Initiative For Chronic Obstructive Lung Disease (GOLD) definition: ”Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease with some significant extrapulmonary effects that may contribute to the severity in individual patients. Its pulmonary component is characterized by airflow limitation that is not fully reversible. The airflow limitation is usually progressive and associated with an abnormal inflammatory response of the lung to noxious particles or gases”. COPD is diagnosed by a chest physician.
  • \-Clinically stable on the basis of clinical picture by chest physician.

Exclusion Criteria

  • \-Lack of motivation for voluntary participation in this study.
  • \-The presence of abnormalities in the lens (e.g. cataract) or retina (e.g. retinal detachment), which makes it impossible to make an image of the retina.

Outcomes

Primary Outcomes

Not specified

Similar Trials